Virtual webinar featuring presentations & discussions on selected abstracts in lung cancer from ASCO 2025. Chaired by Noemí Reguart Moderated by Stephen Liu, Nicolas Girard 25 June | 15:30–17:30 CEST/ 08:30–10:30 CDT/ 14:30–16:30 BST Agenda available soon
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…
A blood clot diagnosis can feel overwhelming, but you’re not alone. Join us for this special PEP Talk tailored to those who are newly diagnosed,…
Virtual webinar featuring presentations & discussions on selected abstracts in lung cancer from ASCO 2025. Chaired by Noemí Reguart Moderated by Stephen Liu, Nicolas Girard…
SSO sponsors educational videoconferences for CGSO Fellows and faculty. This session will focus on Thyroid/Endocrine and consists of two case presentations conducted live by fellows…
PURPOSEORCHARD (ClinicalTrials.gov identifier: NCT03944772) is a phase II, biomarker-directed platform study designed to characterize resistance mechanisms and evaluate novel drug combinations in patients with epidermal…
Rearrangements of the lung adenocarcinoma gene creating oncogenic fusions in anaplastic lymphoma kinase (ALK), of which the most common is echinoderm microtubule-associated protein-like 4 (EML4),…
Join the SSO Breast DSWG, Korean Breast Cancer Society, and Taiwan Breast Cancer Society for a webinar exploring the unique challenges of managing DCIS and…
Only type I MET tyrosine kinase inhibitors (TKIs) are approved for treating MET-altered non-small cell lung cancers (NSCLCs). Preclinically, type II TKIs like cabozantinib can…
This episode of Lung Cancer Considered reviews important lung cancer data presented at ASCO 2025. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephe…
This episode of Lung Cancer Considered reviews important lung cancer data presented at ASCO 2025. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephe…
